B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Zaritsky, Assaf
Kolet, Naor
Abrégé
The present invention relates generally to machine learning and artificial intelligence methods of cell anomaly detection. More specifically, the present invention relates to targeting intracellular anomalies via microscopy-based high-content phenotypic screening and generative neural networks for combinatorial drug screening. As can be seen from the provided description, the claimed invention represents the system and method of cell anomaly detection, which increase reliability of cell anomaly detection. More specifically, the claimed invention provides an assessment of cell inter-component (inter-organelle) organization for detecting cell anomaly.
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
2.
REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF IMMUNE CHECKPOINT MOLECULES
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Elkabets, Moshe
Porgador, Angel
Abrégé
A polynucleotide is provided. The polynucleotide encoding a chimeric polypeptide comprising an amino acid sequence of an immune checkpoint molecule capable of binding a ligand thereof, the immune checkpoint molecule being translationally fused to another amino acid sequence of a cell signaling module such that upon binding of the immune checkpoint molecule to the ligand, the cell signaling module is activated. Also provided other configurations of the polynucleotide, cells comprising the polynucleotides and methods of using the cells expressing the polynucleotides.
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
3.
REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF RECEPTORS ASSOCIATED WITH CANCER AND SELECTING TREATMENT
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Porgador, Angel
Elkabets, Moshe
Abrégé
A polynucleotide encoding a chimeric polypeptide comprising an amino acid sequence of a ligand capable of binding a cancer-associated receptor is provided. The amino acid sequence of the ligand being translationally fused to a heterologous amino acid sequence of a cell signaling module such that upon binding of the amino acid sequence of the ligand to the receptor, the cell signaling module is activated, wherein the ligand or cancer-associated receptor is not an immune checkpoint molecule.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 38/18 - Facteurs de croissanceRégulateurs de croissance
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
C12Q 1/6897 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques faisant intervenir des gènes rapporteurs liés de façon fonctionnelle à des promoteurs
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
4.
AERIAL VEHICLE ALSO CAPABLE OF MOVING ON INCLINED SURFACES
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Zarrouk, David
Abrégé
A flying driving vehicle having a body, a driving interface coupled to the body configured to enable the body to drive on a surface, and one or more driving actuators configured to provide power to the driving interface, a set of propellers coupled to the body, where the propellers' movement keeps the vehicle in place when the surface is in slope, and a controller for controlling the speed of the driving interface, a rotation speed of the set of propellers and a magnitude and direction of thrust applied by the set of propellers.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Ashkenazi, Avraham
Berdichevsky, Yevgeny
Amer-Sarsour, Fatima
Vatine, Gad David
Falik, Daniel
Abrégé
Provided are methods of treating a subject having a disease associated with a polyalanine expansion mutation, by administering to the subject a therapeutically effective amount of an agent capable of upregulating expression or activity of a ubiquitin like modifier activating enzyme 6 (UBA6) in nervous system cells of the subject. Also provided are methods of increasing ubiquitination of an E6AP polypeptide in a cell by an agent capable of specifically upregulating expression or activity of UBA6 and methods of screening for agent capable of specifically modulating expression or activity of UBA6.
A61K 38/00 - Préparations médicinales contenant des peptides
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
A61K 31/711 - Acides désoxyribonucléiques naturels, c.-à-d. contenant uniquement des 2'-désoxyriboses liés à l'adénine, la guanine, la cytosine ou la thymine et ayant des liaisons 3'-5' phosphodiester
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Amiram, Miriam
Gelkop, Sigal
Israeli, Bar
Strugach, Daniela
Abrégé
Mutant aminoacyl-tRNA synthetase (aaRS) proteins are provided. Nucleic acid molecules encoding the mutant aaRSs, orthogonal translation systems comprising the mutant aaRSs or nucleic acid molecules, cells comprising the orthogonal translation systems, as well as methods of using same are also provided.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Guetta, Yoad
Shapiro, Amir
Abrégé
The subject matter discloses a method for replacing a battery for a first vehicle, comprising a second vehicle placing the battery above the first vehicle; releasing the battery from the second vehicle to an inlet in the first vehicle; carrying the battery in a compartment of the first vehicle; coupling the battery to electronic circuitry in the first vehicle, such that the electronic circuitry receives electronic power from the battery. The subject matter also discloses an aerial vehicle used to receive a replacing battery, and a battery replacement system.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Attali, Bernard
Peretz, Shahaf Asher
Haimov, Elvira
Redko, Boris
Raveh, Avi
Yeheskel, Adva
Engel, Hamutal
Etzion, Yoram
Abrégé
Compounds capable of interacting with the calmodulin-PIP2 binding domain of the SK4 channel to thereby interfere with the Ca2+-dependent activation of the SK4 channel and uses thereof in downregulating an activity of an SK4 channel in a subject in need thereof, are disclosed. Also disclosed is a method of identifying a candidate compound that is capable of downregulating an activity of SK4 channel, based on its interaction with the calmodulin-PIP2 binding domain of the SK4 channel.
C07D 235/24 - BenzimidazolesBenzimidazoles hydrogénés avec des hétéro-atomes ou avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement en position 2
C07D 235/30 - Atomes d'azote ne faisant pas partie d'un radical nitro
C07D 263/58 - BenzoxazolesBenzoxazoles hydrogénés avec des hétéro-atomes ou avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement en position 2
A61K 31/4184 - 1,3-Diazoles condensés avec des carbocycles, p. ex. benzimidazoles
A61K 31/423 - Oxazoles condensés avec des carbocycles
B.G. Negev Technologies & Applications Ltd. at Ben-Gurion University (Israël)
University of Maryland, Baltimore (USA)
Inventeur(s)
Ben-Yoav, Hadar
Shukla, Rajendra Prassad
Aroosh, Matan
Kelly, Deanna L.
Abrégé
The invention provides a method of electrochemical detection of clozapine in a whole blood sample or plasma sample, e.g., capillary sample, using an electrochemical microsensor comprising an array of working microelectrodes, i.e., bare and coated; by application of voltammetry and measurement of current as the electrochemical signal, a data set consisting of plurality of electrochemical signals is obtained, to which chemometric methods are applied to quantify clozapine in the sample.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. (Israël)
Inventeur(s)
Lior, Yotam
Lewis, Eli Chaim
Abrégé
The present invention includes mutants of human alpha-1-antitrypsin (mhAAT). Further provided are compositions including the mhAAT and use of same, such as for modulating an immune cell, and treating a condition, such as inflammation.
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
11.
MATURATION OF SPERMATOGONIAL CELLS IN VITRO BT GROWTH FACTORS AND HORMONES
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Huleihel, Mahmoud
Abrégé
Provided are methods of in vitro maturation of spermatogonium by culturing the spermatogonium in a three-dimensional methylcellulose culture system (MCS) in a culture medium which comprises an effective concentration of a factor selected from the group consisting of granulocyte macrophages-colony stimulating factor (GM-CSF), interleukin-1 alpha (IL-1alpha), interleukin-1 beta (IL-1beta) and interleukin-6 (IL-6), under conditions capable of differentiating the spermatogonium into at least meiotic and/or postmeiotic cells, thereby in vitro maturing the spermatogonium.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Vatine, Gad David
Khourin, Roman
Abrégé
Disclosed herein is a device comprising a microelectrode comprising cells cultured on a surface of the microelectrode and a porous membrane comprising an upper surface comprising cultured cells. Further, devices and methods for in in-vitro models of the blood-brain barrier (BBB) and for modeling the transport across this barrier are disclosed.
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
A non-transitory computer readable medium for detection of objects of one or more given classes, the non-transitory computer readable medium stores instructions for: performing an aerial images based (AIB) detection to find multiple object locations; wherein the performing of the AIB detection comprises applying an AIB detection machine learning process on aerial images; performing a ground-level based (GLB) detection of the objects, based on the multiple object locations; wherein the performing of the GLB detection comprises applying a GLB detection machine learning process on ground-level images; and classifying, by a classification machine learning process, objects captured in the ground-level images to a plurality of classes, wherein the plurality of classes comprise the one or more given classes; and responding to the classifying, when finding one or more objects of the one or more given classes.
G06V 10/70 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Zarrouk, David
Abrégé
A flying driving vehicle, comprising a body; a driving interface coupled to the body, configured to enable the body to drive on a surface and one or more driving actuators configured to provide power to the driving interface; a set of propellers coupled to the body; wherein the propellers' movement keep the vehicle in place when the surface is in slope; a controller for controlling the speed of the driving interface, a rotation speed of the set of propellers and a magnitude and direction of thrust applied by the set of propellers
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Elkabets, Moshe
Porgador, Angel
Abrégé
A polynucleotide is provided. The polynucleotide encoding a chimeric polypeptide comprising an amino acid sequence of an immune checkpoint molecule capable of binding a ligand thereof, the immune checkpoint molecule being translationally fused to another amino acid sequence of a cell signaling module such that upon binding of the immune checkpoint molecule to the ligand, the cell signaling module is activated. Also provided other configurations of the polynucleotide, cells comprising the polynucleotides and methods of using the cells expressing the polynucleotides.
C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
16.
REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF IMMUNE CHECKPOINT MOLECULES
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Elkabets, Moshe
Porgador, Angel
Abrégé
A polynucleotide is provided. The polynucleotide encoding a chimeric polypeptide comprising an amino acid sequence of an immune checkpoint molecule capable of binding a ligand thereof, the immune checkpoint molecule being translationally fused to another amino acid sequence of a cell signaling module such that upon binding of the immune checkpoint molecule to the ligand, the cell signaling module is activated. Also provided other configurations of the polynucleotide, cells comprising the polynucleotides and methods of using the cells expressing the polynucleotides.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
17.
ELECTRONIC SENSOR FOR USE IN SOLUTION CONTENT ANALYSIS AND METHOD FOR OPERATING THE SAME
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Shalev, Gil
Abrégé
In one aspect, the invention relates to an integrated circuit lab-on-chip bio-sensor, comprising: (a) a fluid compartment configured to receive a fluid; (b) a sensing layer at the bottom of the fluid compartment, the sensing layer has a top surface comprising molecules that are sensitive to target molecules of the fluid; (c) a readout structure in communication with the sensing layer, the readout circuit is configured to output a signal which is proportional to a sensing of target molecules by the sensing layer; and (d) at least one isolated electrode which is isolated from the fluid, the isolated electrode is configured to apply an electric field along at least an interface between the sensing layer and the fluid that in turn reduces or eliminates excess ion concentration along the interface during sensing.
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
18.
A METHOD FOR IMPRINTING MICROPATTERNS ON A SUBSTRATE OF A CHALCOGENIDE GLASS
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Schvartzman, Mark
Yehuda, Dor
Kassis, Evyatar
Joseph, Shay
Abrégé
In a first embodiment, the invention relates to a method for nanoimprinting a pattern on a chalcogenide-glass substrate, comprising: (A) preparing a soft operational mold, the operational mold comprising an elastomeric matrix and a reinforcement, wherein the matrix is transparent to IR radiation, and the reinforcement is opaque to IR radiation, and the mold further includes a pattern to be replicated to the substrate; (B) placing the mold on a top surface of a chalcogenide-glass substrate to form a structure, and simultaneously applying (i) IR radiation to heat an area at a top surface of the substrate to a temperature T>Tg, where Tg is the glass transition temperature of chalcogenide-glass, and (ii) applying a controlled pressure on the mold to effect penetration to the top surface of the chalcogenide-glass substrate, thereby to replicate the pattern of the mold to the top surface of the substrate; and (C) separating the operational mold from the patterned substrate.
G03F 7/00 - Production par voie photomécanique, p. ex. photolithographique, de surfaces texturées, p. ex. surfaces impriméesMatériaux à cet effet, p. ex. comportant des photoréservesAppareillages spécialement adaptés à cet effet
B81C 1/00 - Fabrication ou traitement de dispositifs ou de systèmes dans ou sur un substrat
19.
SYSTEM AND METHOD FOR DETERMINING AQUEOUS NITRATE CONCENTRATION IN SOLUTION CONTAINING DISSOLVED ORGANIC CARBON
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Arnon, Shlomi
Dahan, Ofer
Yeshno, Elad
Abrégé
The invention relates to a system for determining a level of nitrate in a water sample, including: (a) an optical flow cell which is at least partially transparent and which is configured to contain a sample of water; (b) a first illuminator for illuminating the sample by light in a first wavelength, and a first photodetector for collecting the first-wavelength illumination, following the light passage through the sample; (c) a second illuminator for illuminating the sample within the cell by light in a second, fluorescence-exciting wavelength, and a second photodetector for collecting illumination in a third, fluorescence-emission wavelength from the sample; and (d) an analysis unit for determining the combined effect of nitrate+DOC within the sample on the absorbance of light, determining a concentration of DOC within the sample based on fluorescence emission from the sample, and subtracting the effect of DOC from the combined effect of nitrate+DOC on the absorbance, thereby to determine a concentration of nitrate within the sample.
THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI INSTITUTE) (Israël)
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Klapp, Iftach
Kalantar, Aharon
Dashuta, Artium
Edan, Yael
Gur, Amit
Abrégé
A method of in-situ estimating volume and mass of a plurality of objects comprises: (a) obtaining at least one image including said plurality of objects; (b) detecting said of objects within said image; (c) individually contouring said objects; (d) individually modelling shapes of said objects; and (e) individually estimating a volume and mass of said objects.
G06V 10/75 - Organisation de procédés de l’appariement, p. ex. comparaisons simultanées ou séquentielles des caractéristiques d’images ou de vidéosApproches-approximative-fine, p. ex. approches multi-échellesAppariement de motifs d’image ou de vidéoMesures de proximité dans les espaces de caractéristiques utilisant l’analyse de contexteSélection des dictionnaires
21.
Electrode and a pseudo-capacitor based on the electrode
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Morag, Ahiud
Jelinek, Raz
Abrégé
2) coating onto a progressively etched nickel surface; and partial electrochemical oxidation of said metallic ruthenium to ruthenium oxide. The electrode produced and a pseudo-capacitor based on the electrode are also disclosed.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Karabchevsky, Alina
Gurwich, Joseph
Abrégé
The invention relates to an input or output facet for an on-chip optical waveguide, the facet comprising a grid of gradually expanding unit-cells such as cones or pyramids.
G02B 1/118 - Revêtements antiréfléchissants ayant des structures de surface de longueur d’onde sous-optique conçues pour améliorer la transmission, p. ex. structures du type œil de mite
G02B 6/122 - Éléments optiques de base, p. ex. voies de guidage de la lumière
23.
Synthesis of antimicrobial carbon dots and uses thereof
B.G. NEGEV TECHNOLOGIES & APPLICATIONS, LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Jelinek, Raz
Bhattacharya, Sagarika
Otis, Gil
Abrégé
The present invention relates to antibacterial carbon dots, having aminoguanidine functionality on their outermost surface. The invention further relates to the synthesis of said antibacterial carbon dots, and to the uses of these carbon dots for inhibiting a biofilm formation in the presence of said carbon dots and as fluorescent labeling markers for specific bacteria.
A01N 25/26 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, caractérisés par leurs formes, ingrédients inactifs ou modes d'applicationSubstances réduisant les effets nocifs des ingrédients actifs vis-à-vis d'organismes autres que les animaux nuisibles sous forme de particules revêtues
A01N 35/10 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant deux liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. un radical aldéhyde au moins une des liaisons carbone-hétéro-atome étant une liaison carbone-azote comportant une double liaison carbone-azote
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
24.
SYSTEM AND METHOD FOR REPLACING A BATTERY IN A VEHICLE
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Guetta, Yoad
Shapiro, Amir
Abrégé
The subject matter discloses a method for replacing a battery for a first vehicle, comprising a second vehicle placing the battery above the first vehicle; releasing the battery from the second vehicle to an inlet in the first vehicle; carrying the battery in a compartment of the first vehicle; coupling the battery to electronic circuitry in the first vehicle, such that the electronic circuitry receives electronic power from the battery. The subject matter also discloses an aerial vehicle used to receive a replacing battery, and a battery replacement system.
B60S 5/06 - Approvisionnement des véhicules en batteries ou retrait des batteries des véhicules
B60L 58/12 - Procédés ou agencements de circuits pour surveiller ou commander des batteries ou des piles à combustible, spécialement adaptés pour des véhicules électriques pour la surveillance et la commande des batteries en fonction de l'état de charge [SoC]
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Hirsch, Ann M.
Martinez-Hidalgo, Pilar
Kaplan, Drora
Abrégé
Methods and compositions for increasing one or more plant growth characteristics in a plant are disclosed. The compositions comprise one or more microbial isolates that promote plant growth. Methods include providing an effective amount of a composition comprising one or more microbial isolates that promote one or more plant growth characteristics.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Huleihel, Mahmoud
Abrégé
Provided are methods of in vitro maturation of spermatogonium by culturing the spermatogonium in a three-dimensional methylcellulose culture system (MCS) in a culture medium which comprises an effective concentration of a factor selected from the group consisting of granulocyte macrophages-colony stimulating factor (GM-CSF), interleukin- 1 alpha (IL-1 alpha), interleukin- 1 beta (IL-lbeta) and interleukin-6 (IL-6), under conditions capable of differentiating the spermatogonium into at least meiotic and/or postmeiotic cells, thereby in vitro maturing the spermatogonium.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Katz, Gilad
Shabtai, Asaf
Birman, Yoni
Ido, Ziv
Abrégé
A master-slave scheduling system, comprising (a) a master DRL unit comprising: (i) a queue containing a plurality of item-representations; (ii) a master policy module configured to select a single item-representation from the queue and submit to the slave unit; (iii) a master DRL agent configured to (a) train the master policy module; and (b) receive an updated item-representation from the slave unit, and update the queue;
(b) The slave DRL unit comprising: (i) a slave policy module receiving a single item-representation, selecting a single task entry and submitting to a slave environment for performance; (ii) a slave DRL agent configured to: (a) train the slave policy module; (b) receive an item-representation from the master DRL unit, and submit to the slave policy module; (c) receive an updated item-representation from the slave's environment, and submit the same to the master DRL unit; and (iii) the slave DRL agent.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Kuperman, Alon
Abrégé
A high-frequency resonant power conversion system for transferring power from an oscillator to a load or vice-versa, the system including components with at least one fluctuating parameter and is configured to control the value of a defined variable selected from: a certain current, a certain voltage, a phase difference between a certain voltage and a certain current, and a certain power; the system further including a virtual impedance creation loop which is configured to create a virtual component, the virtual component forming a basis for changing amplitude and a phase of the oscillator, thereby to compensate for a deviation from the controlled variable due to the fluctuations.
H02M 5/08 - Transformation d'une puissance d'entrée en courant alternatif en une puissance de sortie en courant alternatif, p. ex. pour changement de la tension, pour changement de la fréquence, pour changement du nombre de phases sans transformation intermédiaire en courant continu par convertisseurs statiques utilisant des impédances utilisant des condensateurs uniquement
H02M 5/16 - Transformation d'une puissance d'entrée en courant alternatif en une puissance de sortie en courant alternatif, p. ex. pour changement de la tension, pour changement de la fréquence, pour changement du nombre de phases sans transformation intermédiaire en courant continu par convertisseurs statiques utilisant des transformateurs pour la transformation de la fréquence
H02M 5/297 - Transformation d'une puissance d'entrée en courant alternatif en une puissance de sortie en courant alternatif, p. ex. pour changement de la tension, pour changement de la fréquence, pour changement du nombre de phases sans transformation intermédiaire en courant continu par convertisseurs statiques utilisant des tubes à décharge avec électrode de commande ou des dispositifs à semi-conducteurs avec électrode de commande utilisant des dispositifs du type triode ou transistor exigeant l'application continue d'un signal de commande pour transformation de la fréquence
H02M 1/44 - Circuits ou dispositions pour corriger les interférences électromagnétiques dans les convertisseurs ou les onduleurs
29.
SYSTEM AND METHOD FOR DETERMINING AQUEOUS NITRATE CONCENTRATION IN SOLUTION CONTAINING DISSOLVED ORGANIC CARBON
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Arnon, Shlomi
Dahan, Ofer
Yeshno, Elad
Abrégé
The invention relates to a system for determining a level of nitrate in a water sample, comprising: (a) an optical flow cell which is at least partially transparent and which is configured to contain a sample of water; (b) a first illuminator for illuminating the sample by light in a first wavelength, and a first photodetector for collecting the first-wavelength illumination, following the light passage through the sample; (c) a second illuminator for illuminating the sample within the cell by light in a second, fluorescence-exciting wavelength, and a second photodetector for collecting illumination in a third, fluorescence-emission wavelength from the sample; and (d) an analysis unit for determining the combined effect of nitrate+DOC within the sample on the absorbance of light, determining a concentration of DOC within the sample based on fluorescence emission from the sample, and subtracting the effect of DOC from the combined effect of nitrate+DOC on the absorbance, thereby to determine a concentration of nitrate within the sample.
G01N 21/17 - Systèmes dans lesquels la lumière incidente est modifiée suivant les propriétés du matériau examiné
G01J 1/42 - Photométrie, p. ex. posemètres photographiques en utilisant des détecteurs électriques de radiations
G01N 21/63 - Systèmes dans lesquels le matériau analysé est excité de façon à ce qu'il émette de la lumière ou qu'il produise un changement de la longueur d'onde de la lumière incidente excité optiquement
G01J 3/10 - Aménagements de sources lumineuses spécialement adaptées à la spectrométrie ou à la colorimétrie
G01J 3/42 - Spectrométrie d'absorptionSpectrométrie à double faisceauSpectrométrie par scintillementSpectrométrie par réflexion
G01N 21/33 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière ultraviolette
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (Israël)
Inventeur(s)
Golan, Yoav
Shapiro, Amir
Rimon, Elon
Hason, Noam Moshe
Abrégé
The present invention relates to a robotic maneuvering system for maneuvering objects by means of an adhesive attachment. The robotic maneuvering system comprises a gripper finger connected to a gripper arm. The gripper finger is configured to grasp an object to be manipulated, by means of an adhesive contact. The gripper arm maneuvers the object to a desired location and the gripper finger releases the object at the desired location. The present invention also relates to a corresponding method.
B65C 3/00 - Étiquetage sur surfaces autres que les surfaces planes
B65G 47/90 - Dispositifs pour saisir et déposer les articles ou les matériaux
B65B 9/00 - Enserrage d'objets les uns à la suite des autres ou de quantités de matériaux, p. ex. liquides ou semi-liquides, dans des bandes plates, pliées ou tubulaires faites de feuilles en matière soupleDivision des tubes flexibles remplis pour former des paquets
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
RAFAEL ADVANCED DEFENSE SYSTEMS LTD. (Israël)
Inventeur(s)
Schvartzman, Mark
Yehuda, Dor
Kassis, Evyatar
Joseph, Shay
Abrégé
T>Tgg g g is the glass transition temperature of chalcogenide-glass, and (ii) applying a controlled pressure on the mold to effect penetration to the top surface of the chalcogenide-glass substrate, thereby to replicate the pattern of the mold to the top surface of the substrate; and (C) separating the operational mold from the patterned substrate.
B81C 1/00 - Fabrication ou traitement de dispositifs ou de systèmes dans ou sur un substrat
G03F 7/00 - Production par voie photomécanique, p. ex. photolithographique, de surfaces texturées, p. ex. surfaces impriméesMatériaux à cet effet, p. ex. comportant des photoréservesAppareillages spécialement adaptés à cet effet
32.
PROCESS FOR PREPARING CUBIC PI-PHASE MONOCHALCOGENIDES
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Golan, Yuval
Abutbul, Ran Eitan
Segev, Elad
Argaman, Uri
Makov, Guy
Toutian, Eyal
Abrégé
233+ associated with a counter anion, wherein R is saturated or unsaturated hydrocarbyl, which may be the same or different in the uncharged and charged forms, and recovering from the reaction mixture an essentially pure cubic phase of the monochalcogenides.
H01L 45/00 - Dispositifs à l'état solide spécialement adaptés pour le redressement, l'amplification, la production d'oscillations ou la commutation, sans barrière de potentiel ni barrière de surface, p.ex. triodes diélectriques; Dispositifs à effet Ovshinsky; Procédés ou appareils spécialement adaptés à la fabrication ou au traitement de ces dispositifs ou de leurs parties constitutives
B.G. Negev Technologies & Applications Ltd. at Ben-Gurion University (Israël)
Inventeur(s)
Karabchevsky, Alina
Abrégé
The invention relates to a method for creating a space of invisibility, which comprises: (a) providing a metamaterial plate having a subwavelength thickness, said metamaterial plate having bottom and top surfaces; (b) radiating the bottom surface of the metamaterial plate by a primary radiation thereby to form a space of invisibility above the top surface of the metamaterial plate, said space of invisibility being located within a space of a secondary radiation above the metamaterial plate which is in turn formed as a result of said primary radiation passing through metamaterial plate.
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Katoshevski, David
Brenner, Asher
Meidan, Daphne
Halfi, Eran
Abrégé
Disclosed herein are systems and methods of purification of liquid from colloidal particles. More specifically, disclosed are systems and methods for treating water by effecting aggregation of colloidal particles and thus improving their sedimentation, by enhancing grouping of the particles using accelerating, decelerating, and reversing velocity gradients within the liquid. The disclosed methods and systems for water treatment allow for continuous treatment of a contaminated water stream in a single flocculation and sedimentation vessel (i.e. a hybrid process).
C02F 1/34 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout au moyen d'oscillations mécaniques
B01D 21/28 - Dispositifs mécaniques auxiliaires pour accélérer la sédimentation, p. ex. par des vibrateurs
C02F 1/52 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par floculation ou précipitation d'impuretés en suspension
B01F 31/65 - Mélangeurs avec mécanismes à secousses, oscillants ou vibrants les matières à mélanger étant directement soumises à un mouvement de pulsation, p. ex. au moyen d'un piston oscillant ou d'une colonne d'air
C02F 103/00 - Nature de l'eau, des eaux résiduaires ou des eaux ou boues d'égout à traiter
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Karabchevsky, Alina
Gurwich, Joseph
Abrégé
The invention relates to an input or output facet for an on- chip optical waveguide, the facet comprising a grid of gradually expanding unit-cells such as cones or pyramids.
G02B 6/12 - Guides de lumièreDétails de structure de dispositions comprenant des guides de lumière et d'autres éléments optiques, p. ex. des moyens de couplage du type guide d'ondes optiques du genre à circuit intégré
H01L 33/22 - Surfaces irrégulières ou rugueuses, p.ex. à l'interface entre les couches épitaxiales
36.
AN ELECTRODE AND A PSEUDO-CAPACITOR BASED ON THE ELECTRODE
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Morag, Ahiud
Jelinek, Raz
Abrégé
The invention provides a process for preparing an electrode, comprising: electrodeposition of metallic ruthenium/ruthenium oxide (Ru(0)22) coating onto a progressively etched nickel surface; and partial electrochemical oxidation of said metallic ruthenium to ruthenium oxide. The electrode produced and a pseudo-capacitor based on the electrode are also disclosed.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Jelinek, Raz
Bhattacharya, Sagarika
Otis, Gil
Abrégé
The present invention relates to antibacterial carbon dots, having aminoguanidine functionality on their outermost surface. The invention further relates to the synthesis of said antibacterial carbon dots, and to the uses of these carbon dots for inhibiting a biofilm formation in the presence of said carbon dots and as fluorescent labeling markers for specific bacteria.
G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p. ex. utilisation de bandes de papier indicateur
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Karabchevsky, Alina
Abrégé
The invention relates to a method for the preparation of a layer containing a plurality of linear carbyne chains, the method comprising (a) applying laser ablation on a piece of shungite in a liquid, followed by laser irradiation of the resultant carbon structures within the liquid in the presence of stabilizing metal nanoparticles, thereby to form a colloidal solution; and (b) subjecting at least a portion of said colloidal solution to AC voltage while the solution is allowed to dry, thereby to create a two-dimensional layer containing a plurality of carbyne chains.
C08G 61/00 - Composés macromoléculaires obtenus par des réactions créant une liaison carbone-carbone dans la chaîne principale de la macromolécule
B01J 13/00 - Chimie des colloïdes, p. ex. production de substances colloïdales ou de leurs solutions, non prévue ailleursFabrication de microcapsules ou de microbilles
39.
BACTERIA FROM MEDICAGO ROOT NODULES AS PLANT PROBIOTIC BACTERIA FOR AGRICULTURE
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Hirsch, Ann M.
Martinez-Hidalgo, Pilar
Kaplan, Drora
Abrégé
Methods and compositions for increasing one or more plant growth characteristics in a plant are disclosed. The compositions comprise one or more microbial isolates that promote plant growth. Methods include providing an effective amount of a composition comprising one or more microbial isolates that promote one or more plant growth characteristics.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
C05F 11/08 - Engrais organiques comportant l'addition de cultures bactériennes, de mycélium ou similaires
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Zarrouk, David
Abrégé
The present invention relates to a robot device comprising a chain comprising a plurality of fixedly connected links and a mobile actuator movable thereon configured to change a position of a link relative to a position of an adjacent link; wherein said mobile actuator comprises at least a first motor to drive it along said chain of connected links; and wherein said mobile actuator is engageable with a position-determining element in said link.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Herskowitz, Mordechay
Hos, Tomy
Abrégé
2 is in the range of 1:0.5 to 1:0.9, catalytically hydrogenating said carbon monoxide in said hydrogenation reactor, condensing the effluent of said hydrogenation reactor to recover one or more organic liquid(s) and an aqueous solution, feeding a non-condensable component of said effluent into an oligomerization reactor; condensing an effluent discharged from the oligomerization reactor to obtain an additional organic liquid and an additional gaseous stream, separating said additional organic liquid, and either combusting said additional gaseous stream to produce heat and electricity, or processing same to obtain recyclable gaseous streams utilizable in said process.
C01B 3/12 - Production d'hydrogène ou de mélanges gazeux contenant de l'hydrogène par réaction de composés inorganiques comportant un hydrogène lié électropositivement, p. ex. de l'eau, des acides, des bases, de l'ammoniac, avec des agents réducteurs inorganiques par réaction de la vapeur d'eau avec l'oxyde de carbone
C10G 50/00 - Production de mélanges d'hydrocarbures liquides à partir d'hydrocarbures à nombre inférieur d'atomes de carbone, p. ex. par oligomérisation
C01B 3/38 - Production d'hydrogène ou de mélanges gazeux contenant de l'hydrogène par réaction de composés organiques gazeux ou liquides avec des agents gazéifiants, p. ex. de l'eau, du gaz carbonique, de l'air par réaction d'hydrocarbures avec des agents gazéifiants avec des catalyseurs
C01B 3/50 - Séparation de l'hydrogène ou des gaz contenant de l'hydrogène à partir de mélanges gazeux, p. ex. purification
C10G 2/00 - Production de mélanges liquides d'hydrocarbures de composition non définie à partir d'oxydes de carbone
C10K 3/02 - Modification de la composition chimique des gaz combustibles contenant l'oxyde de carbone en vue de produire un carburant amélioré, p. ex. un carburant de pouvoir calorifique différent qui peut ne pas contenir d'oxyde de carbone par traitement catalytique
B01J 37/02 - Imprégnation, revêtement ou précipitation
C25B 15/08 - Alimentation ou vidange des réactifs ou des électrolytesRégénération des électrolytes
B01J 35/10 - Catalyseurs caractérisés par leur forme ou leurs propriétés physiques, en général solides caractérisés par leurs propriétés de surface ou leur porosité
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Huleihel, Mahmoud
Abrégé
in vitroin vitroin vitroin vitro matured sperm obtainable according to the method of the invention and methods of treating subjects in need of mature sperm cells.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Sintov, Amnon
Abrégé
The invention provides a nano-sized particle comprising a cross-linked polymer, wherein the polymer is selected from the group consisting of a polyacrylic acid homopolymer; polymethacrylic acid homopolymer; poly(alkylcyanoacrylate) polymer; a copolymer comprising at least two monomers selected from acrylic acid, methacrylic acid, hydroxyethyl acrylate, hydroxyethyl methacrylate, and alkyl cyanoacrylate/cyanoacrylic acid monomers; carboxymethyl cellulose; alginic acid polymer, polylactic-polyglycolic acid (PLGA), and xanthan gum; and wherein said polymer is cross-linked with a metal ion. A process for preparing such particles is also provided.
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Jelinek, Raz
Teradal, Nagappa
Morag, Ahiud
Abrégé
The present invention discloses a novel capacitive vapor sensor comprising porous immobilized graphene oxide (pGO) on an electrode surface. Also disclosed is an in-situ process for the preparation of this sensor and various uses thereof.
G01N 27/22 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la capacité
45.
METHOD AND SYSTEM FOR ESTIMATING POTENTIAL DISTRIBUTION ON CORTICAL SURFACE
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Geva, Amir B.
Shavit, Reuven
Haor, Dror
Stern, Yaki
Peremen, Ziv
Abrégé
A method of estimating potential distribution over a cortical surface of a brain of a subject is disclosed. The method comprises: obtaining encephalogram (EG) data recorded from a scalp surface of the head, and head model data describing a geometry of the head and electrical property distribution of tissues within the head. The method further comprises calculating differentials of the EG data over the scalp surface, calculating volumetric distribution of electrical potential between the cortex and scalp surfaces using the EG data and the differentials, and estimating the potential distribution over the cortical surface based on the volumetric distribution.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Vidavsky, Yuval
Yudovin-Farber, Ira
Lemcoff, Norberto Gabriel
Ben Asuly, Amos
Ginzburg, Yakov
Saha, Sukdeb
Abrégé
Methods for fabricating three-dimensional objects by 3D-inkjet printing technology, which utilize dicyclopentadiene (DCPD)-based curable materials that polymerize via ring-opening metathesis polymerization (ROMP) for fabricating the object, are provided. Curable formulations and cured materials formed therefrom, containing the dicyclopentadiene (DCPD)-based curable materials are also provided. The dicyclopentadiene (DCPD)-based curable materials and the cured materials formed therefrom are characterized by reduced or nullified malodor.
B29C 39/00 - Moulage par coulée, c.-à-d. en introduisant la matière à mouler dans un moule ou entre des surfaces enveloppantes sans pression significative de moulageAppareils à cet effet
C07C 43/18 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle autre que ceux d'un cycle aromatique à six chaînons
C07C 69/013 - Esters d'alcools dont le groupe hydroxyle estérifié est lié à un atome de carbone d'un cycle autre qu'un cycle aromatique à six chaînons
C07D 233/64 - Composés hétérocycliques contenant des cycles diazole-1, 3 ou diazole-1, 3 hydrogéné, non condensés avec d'autres cycles comportant deux liaisons doubles entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec des radicaux hydrocarbonés substitués, liés aux atomes de carbone du cycle, p. ex. histidine
B41J 2/485 - Machines à écrire ou mécanismes d'impression sélective caractérisés par le procédé d'impression ou de marquage pour lequel ils sont conçus caractérisés par le procédé de formation de caractères applicable à plusieurs types de procédés d'impression ou de marquage
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (Israël)
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Deouell, Leon Y.
Geva, Amir B.
Fuhrmann Alpert, Galit
Manor, Ran El
Shalgi, Shani
Abrégé
Systems and method for classifying EEG signals of a human subject generated responsive to a series of images containing target images and non-target images. The EEG signals are in a spatio-temporal representation. The time points are classified independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights that are used to amplify the spatio-temporal representation, to create a spatially-weighted representation. Principal Component Analysis is used on a temporal domain for dimensionality reduction, separately for each spatial channel of the signals, to create a projection, which is applied to the spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation. The temporally approximated spatially weighted representation is classified over the channels, using said linear discriminant classifier, to yield a binary decisions series indicative of each image of the images series as either belonging to said target image or to said non-target image.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD. AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Jelinek, Raz
Abrégé
Colorimetric and/or fluorescent detectors, which include a polydiacetylene (PDA) film deposited on a polymethylmetacrylate (PMMA) substrate. There are also colorimetric and/or fluorescent detectors which have a solid organic matrix comprising one or more PDAs deposited on the PMMA substrate, wherein the PDA includes polymerized units of one or more diacetylene monomers, and wherein the matrix further comprises at least one recognition element of an analyte. There are also methods for detecting analytes using this detector, uses thereof and a methods for its preparation.
C08F 138/00 - Homopolymères de composés contenant une ou plusieurs liaisons triples carbone-carbone
G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p. ex. utilisation de bandes de papier indicateur
B05D 1/00 - Procédés pour appliquer des liquides ou d'autres matériaux fluides aux surfaces
B05D 3/06 - Traitement préalable des surfaces sur lesquelles des liquides ou d'autres matériaux fluides doivent être appliquésTraitement ultérieur des revêtements appliqués, p. ex. traitement intermédiaire d'un revêtement déjà appliqué, pour préparer les applications ultérieures de liquides ou d'autres matériaux fluides par exposition à des rayonnements
G01N 21/00 - Recherche ou analyse des matériaux par l'utilisation de moyens optiques, c.-à-d. en utilisant des ondes submillimétriques, de la lumière infrarouge, visible ou ultraviolette
Hadasit Medical Research Services and Development Ltd. (Israël)
B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (Israël)
Inventeur(s)
Cohen, Smadar
Ilan, Yaron
Shteyer, Eyal
Ben-Ya'Acov, Ami
Abrégé
Disclosed herein are compositions, methods and uses utilizing alginate compositions, for treating, preventing and/or reducing liver damage induced by a hepatotoxic agent, and for treating a medical condition treatable by a hepatotoxic agent, in which an alginate composition is administered prior to, concomitant with, or shortly after exposure to a hepatotoxic agent. Also disclosed are pharmaceutical compositions comprising a hepatotoxic agent and an alginate composition and uses thereof for treating medical conditions treatable by the hepatotoxic agent.
A61K 31/167 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide ayant l'atome d'azote d'un groupe carboxamide lié directement au cycle aromatique, p. ex. lidocaïne, paracétamol
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Giterman, Robert
Teman, Adam
Meinerzhagen, Pascal
Burg, Andreas
Fish, Alexander
Abrégé
A gain cell includes a write bit line input, a read bit line output, a write trigger input and a read trigger input. The gain cell also includes a write transistor, retention element and read transistor. Each of the transistors includes a respective first diffusion connection, gate connection and second diffusion connection. The write transistor first diffusion connection is connected to the write bit line input and the write transistor gate connection is connected to the write trigger input. The read transistor first diffusion connection being connected to the read bit line output and the second diffusion connection is connected to the read trigger input. The retention element buffers between write transistor and the read transistor during data retention. The retention element also connects or disconnects a write transistor diffusion connection to/from a constant voltage in accordance with a retained data level at the read transistor gate connection.
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Cohen, Smadar
Etzion, Yoram
Rotenberg, Menahem
Abrégé
A method of pacing a heart of a subject, is disclosed. The heart has a magnetically responsive object therein. The method comprises non-invasively applying to the heart an alternating magnetic field selected to vibrate the object against a wall of the heart such as to effect mechanical stimulation of the heart, thereby pacing the heart.
An isolated antibody comprising an antigen recognition region which comprises six complementarity determining region (CDR) amino acid sequences as set forth in: (i) SEQ ID NOs: 4, 6, 8, 12, 14 and 16; (ii) SEQ ID NOs: 20, 22, 24, 28, 30 and 32; or (iii) SEQ ID NOs: 36, 38, 40, 44, 46 and 48, is disclosed. Methods of producing same as well as pharmaceutical composition comprising same and uses thereof are disclosed.
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
53.
CLASSIFYING EEG SIGNALS IN RESPONSE TO VISUAL STIMULUS
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israël)
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Deouell, Leon Y.
Geva, Amir B.
Fuhrmann Alpert, Galit
Manor, Ran El
Shalgi, Shani
Abrégé
Systems and method for conduction of single trial classification of EEG signals of a human subject generated responsive to a series of images containing target images and non-target images, the method comprising: obtaining said EEG signals in a spatio-temporal representation comprising time points and respective spatial distribution of said EEG signals; classifying said time points independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights; using said spatio-temporal discriminating weights to amplify said spatio-temporal representation by said spatio-temporal discriminating weights at tempo-spatial points respectively, to create a spatially-weighted representation; using Principal Component Analysis (PCA) on a temporal domain for dimensionality reduction, separately for each spatial channel of said EEG signals, to create a PCA projection; applying said PCA projection to said spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation containing for each spatial channel, PCA coefficients for said plurality of principal temporal projections; and classifying said temporally approximated spatially weighted representation, over said number of channels, using said linear discriminant classifier, to yield a binary decisions series indicative of each image of the images series as either belonging to said target image or to said non-target image.
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Israël)
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Deouell, Leon, Y.
Geva, Amir, B.
Fuhrmann Alpert, Galit
Manor, Ran, El
Shalgi, Shani
Abrégé
Systems and method for conduction of single trial classification of EEG signals of a human subject generated responsive to a series of images containing target images and non-target images, the method comprising: obtaining said EEG signals in a spatio-temporal representation comprising time points and respective spatial distribution of said EEG signals; classifying said time points independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights; using said spatio-temporal discriminating weights to amplify said spatio-temporal representation by said spatio-temporal discriminating weights at tempo-spatial points respectively, to create a spatially-weighted representation; using Principal Component Analysis (PCA) on a temporal domain for dimensionality reduction, separately for each spatial channel of said EEG signals, to create a PCA projection; applying said PCA projection to said spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation containing for each spatial channel, PCA coefficients for said plurality of principal temporal projections; and classifying said temporally approximated spatially weighted representation, over said number of channels, using said linear discriminant classifier, to yield a binary decisions series indicative of each image of the images series as either belonging to said target image or to said non-target image.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G06K 9/00 - Méthodes ou dispositions pour la lecture ou la reconnaissance de caractères imprimés ou écrits ou pour la reconnaissance de formes, p.ex. d'empreintes digitales
G06F 19/00 - Équipement ou méthodes de traitement de données ou de calcul numérique, spécialement adaptés à des applications spécifiques (spécialement adaptés à des fonctions spécifiques G06F 17/00;systèmes ou méthodes de traitement de données spécialement adaptés à des fins administratives, commerciales, financières, de gestion, de surveillance ou de prévision G06Q;informatique médicale G16H)
55.
USE OF ALGINATE COMPOSITIONS IN PREVENTING OR REDUCING LIVER DAMAGE CAUSED BY A HEPATOTOXIC AGENT
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (Israël)
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Cohen, Smadar
Ilan, Yaron
Shteyer, Eyal
Ben-Ya'Acov, Ami
Abrégé
Disclosed herein are compositions, methods and uses utilizing alginate compositions, for treating, preventing and/or reducing liver damage induced by a hepatotoxic agent, and for treating a medical condition treatable by a hepatotoxic agent, in which an alginate composition is administered prior to, concomitant with, or shortly after exposure to a hepatotoxic agent. Also disclosed are pharmaceutical compositions comprising a hepatotoxic agent and an alginate composition and uses thereof for treating medical conditions treatable by the hepatotoxic agent.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (Israël)
B.G. NEGEV TECHNOLOGIES & APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (Israël)
Inventeur(s)
Cohen, Smadar
Ilan, Yaron
Shteyer, Eyal
Ben-Ya'Acov, Ami
Abrégé
Compositions comprising an alginate, a source of sodium ions and a carrier (e.g., a pharmaceutically acceptable carrier), which are characterized by reduced association of the alginate chains and hence by at least one of: (i) a zeta potential weaker than -25 mV, at a concentration of 0.5 % (w/v) alginate in the carrier; and (ii) a diffusion coefficient of at least 10-8 cm2/millisecond, at a concentration of 0.5 % (w/v) alginate in the carrier, are disclosed. Also disclosed are uses of the composition and methods utilizing the composition for treating inflammatory bowel disease, liver damage, diseases and disorders, for treating a medical condition treatable by a hepatotoxic agent and for reducing or preventing liver damage, including liver damage caused by a hepatotoxic agent.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A method for designing a dual-mode logic circuit which is selectably operational in static and dynamic modes is performed as follows. A basis library with a DML inverter and dual-mode logic (DML) bicells is provided. Each DML bicell includes a type-A DML logic gate with a clock input and a type-B DML logic gate with an inverted clock input. A pseudo-static library is formed from the basis library by modifying each bicell of the basis library and specifying at least one dynamic timing parameter. A dynamic library is formed from the basis library by specifying dynamic timing parameters for the basis library DML inverter and bicells. Logic behavior of the required logic circuit is defined. An initial logic circuit design synthesized from the pseudo-static library and the defined logic behavior. Finally, a dynamic circuit design is formed by replacing modified bicells with corresponding bicells from the dynamic library.